ES456048A1 - Pyridoxine derivatives - Google Patents
Pyridoxine derivativesInfo
- Publication number
- ES456048A1 ES456048A1 ES456048A ES456048A ES456048A1 ES 456048 A1 ES456048 A1 ES 456048A1 ES 456048 A ES456048 A ES 456048A ES 456048 A ES456048 A ES 456048A ES 456048 A1 ES456048 A1 ES 456048A1
- Authority
- ES
- Spain
- Prior art keywords
- formula
- nitrogen atom
- pyridoxine derivatives
- lower alcohol
- pyridoxine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
- C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Preparation process of pyridoxine derivatives of formula ** (Formula) ** in which R1 and R2 are hydrogen or together form the isopropylidene radical, R3 and R4, identical or different from each other, are lower alcohol or lower aralkohyl or form, together with the nitrogen atom to which they are attached, a saturated heterocycle with 4 to 8 secondary chains, possibly including, as a second heteroatom, a sulfur, oxygen or nitrogen atom, the latter being able to be substituted by a phenyl, itself carrying, optionally, a halogen, a trifluoromethyl, a lower alcohol or a lower alkoxy and n is 2 or 3. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7604825A FR2341311A1 (en) | 1976-02-20 | 1976-02-20 | PYRIDOXINE DERIVATIVES |
Publications (1)
Publication Number | Publication Date |
---|---|
ES456048A1 true ES456048A1 (en) | 1978-02-16 |
Family
ID=9169423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES456048A Expired ES456048A1 (en) | 1976-02-20 | 1977-02-18 | Pyridoxine derivatives |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS6042792B2 (en) |
BE (1) | BE851461A (en) |
DE (1) | DE2707135A1 (en) |
DK (1) | DK146509C (en) |
ES (1) | ES456048A1 (en) |
FR (1) | FR2341311A1 (en) |
GB (1) | GB1533954A (en) |
IE (1) | IE44696B1 (en) |
LU (1) | LU76787A1 (en) |
NL (1) | NL7701666A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2428640A1 (en) * | 1978-06-12 | 1980-01-11 | Parcor | 5-Piperazino:alkoxy:methyl-pyridine cpds. - with antiinflammatory, diuretic and vaso-protective properties |
JPH0515517U (en) * | 1991-07-31 | 1993-02-26 | 日本電気株式会社 | Primary radiator mounting structure |
US5585388A (en) * | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
WO2024084056A1 (en) * | 2022-10-21 | 2024-04-25 | Etherna Immunotherapies Nv | Ionizable lipids |
-
1976
- 1976-02-20 FR FR7604825A patent/FR2341311A1/en active Granted
-
1977
- 1977-02-09 IE IE268/77A patent/IE44696B1/en unknown
- 1977-02-16 BE BE174953A patent/BE851461A/en not_active IP Right Cessation
- 1977-02-17 LU LU76787A patent/LU76787A1/xx unknown
- 1977-02-17 NL NL7701666A patent/NL7701666A/en not_active Application Discontinuation
- 1977-02-18 GB GB6976/77A patent/GB1533954A/en not_active Expired
- 1977-02-18 ES ES456048A patent/ES456048A1/en not_active Expired
- 1977-02-18 DE DE19772707135 patent/DE2707135A1/en not_active Ceased
- 1977-02-18 DK DK69777A patent/DK146509C/en not_active IP Right Cessation
- 1977-02-19 JP JP52017634A patent/JPS6042792B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IE44696B1 (en) | 1982-02-24 |
NL7701666A (en) | 1977-08-23 |
DK69777A (en) | 1977-08-21 |
BE851461A (en) | 1977-08-16 |
FR2341311B1 (en) | 1979-10-05 |
IE44696L (en) | 1977-08-20 |
JPS52122375A (en) | 1977-10-14 |
FR2341311A1 (en) | 1977-09-16 |
LU76787A1 (en) | 1977-07-06 |
DK146509B (en) | 1983-10-24 |
DK146509C (en) | 1984-04-02 |
DE2707135A1 (en) | 1977-08-25 |
GB1533954A (en) | 1978-11-29 |
JPS6042792B2 (en) | 1985-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG28709A3 (en) | Method of obtaining of 3- (1- pyrazolyl)- pyridazine derivatives | |
ES456048A1 (en) | Pyridoxine derivatives | |
ES446598A1 (en) | Piperazine derivatives | |
BG30016A3 (en) | Method for obtaining of bis / nitro zoureid /- polyol derivatives | |
ES419019A1 (en) | Indolo-2,3-c quinolinone derivatives | |
ES444036A1 (en) | Process for the preparation of 2-2-thienyl-ethylamine and derivatives thereof | |
FI792586A (en) | ALFA-AMINOFENYLAETTIKSSYRADERIVAT | |
ES440438A1 (en) | Procedure for the preparation of new derivatives of fenilbutazona. (Machine-translation by Google Translate, not legally binding) | |
ES453121A1 (en) | Substituted aminoalkylaminopyridine compounds | |
ES445922A1 (en) | Benzofuranone compounds | |
ES460297A1 (en) | 6,11-dihydrodibenzo-(b. e.)-thiepin-11-one-3-aldehyde and 3-acetal derivatives | |
ES465044A1 (en) | 8-adamantylaminomethyl ergolene derivatives | |
ES377420A1 (en) | Procedure for preparation of derivatives of hydroxymethyl-5 oxazoldinone-2 replaced in 3. (Machine-translation by Google Translate, not legally binding) | |
ES452491A1 (en) | Piperazine derivatives | |
ES457102A1 (en) | Preparation of 11tertiary alkyll33 *substituted furyl* urea | |
ES433492A1 (en) | Procedure for preparing benzo-2-4-tiacepinas. (Machine-translation by Google Translate, not legally binding) | |
ES375526A1 (en) | A procedure for the preparation of aminocarbonylalkilic compounds n, N-disustitute. (Machine-translation by Google Translate, not legally binding) | |
ES483138A1 (en) | A procedure for the preparation of tienotiacin derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES426329A1 (en) | A procedure for the preparation of new derivatives of 1,2,3,4-tetrahidroisoquinoleina. (Machine-translation by Google Translate, not legally binding) | |
ES447263A1 (en) | Procedure for preparation of piperazinilpropionamidas. (Machine-translation by Google Translate, not legally binding) | |
ES452479A1 (en) | A procedure for the preparation of naftalene derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES373145A1 (en) | Procedure for the preparation of N-substitute N-bencenosulfonilureas. (Machine-translation by Google Translate, not legally binding) | |
ES457552A1 (en) | Amino-alkoxycycloalkanes | |
ES457657A1 (en) | A procedure for the preparation of new derivatives of N- (heterocicaminocarbonil) (Machine-translation by Google Translate, not legally binding) | |
ES463284A2 (en) | 1-(3,3,3-triarylalkyl)-4-phenyl-piperidine-methanol ethers |